Posted in | News | Gold

Punchline Resources Announces Positive Results from Empress Project

Punchline Resources Ltd. (OTCQB: PUNL) (OTCBB: PUNL) ("Punchline" or the "Company") is pleased to announce that the Company has received additional positive sample results from exploration recently conducted at the Empress Project, located approximately 26 miles south of Goldfield, Nevada.

The additional samples were taken from underground workings previously known as Adit 3 of the historic Empress Mine.

As part of the ongoing exploration program currently being conducted at the Empress Project, geologists collected five underground rock chip channel samples taken across exposed quartz veins at various accessible points along the length of the Empress Mine Adit 3 horizontal tunnel. The samples target an east-west trending, moderately south dipping quartz vein system that was believed to be mined by previous operators of the property. The samples were securely shipped to ALS Chemex in Reno, Nevada for accurate fire assaying.

Each of the five samples returned significant amounts of high-grade gold ranging from 10.35 to 28.8 g/t and returned silver values ranging from 4.5 to 21.7 g/t. The Adit 3 area is one of several high-priority targets at Empress currently being considered for a drilling program in the near future.

"It appears that we have confirmed another potential high-grade gold and silver drill target at our Empress Project in Nevada," said Ramzan Savji, CEO and President of Punchline. "It is worth noting that a very large percentage of our samples taken so far at Empress have returned high values of both gold and silver. This apparent consistency of the vein mineralization is another factor that leads us to believe that we have a significant opportunity to develop a new mine at Empress."

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.